One World Products, Inc.
OWPCOTCHealthcare · Pharmaceutical Preparations · NV · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | |
|---|---|---|---|---|---|---|
| Revenue | $4,863 | $7,589 | $125,662 | $38,264 | $59,568 | — |
| Operating income | −$1.9M | −$2.1M | −$2.2M | −$3.2M | −$7.9M | −$5.8M |
| Net income | −$3.9M | −$4.0M | −$3.1M | −$3.8M | −$8.0M | −$6.2M |
| Total assets | $68,300 | $98,882 | $3.2M | $2.9M | $1.4M | $1.8M |
| Total liabilities | $5.3M | $3.9M | $4.2M | $1.7M | $1.9M | $1.6M |
| Equity | −$9.9M | −$8.3M | −$5.8M | −$3.1M | −$2.0M | $261,394 |
| EPS (diluted) | $-0.04 | $-0.05 | $-0.05 | $-0.06 | — | — |
| Shares out. | 104.3M | 70.2M | 65.9M | 61.3M | 45.7M | 39.9M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2024- Operating margin
- −38494.6%
- Net margin
- −80917.4%
- Return on equity
- 39.7%
- Return on assets
- −5761.4%
- Return on capital (ROCE)
- —
- Liabilities / assets
- 7694.3%
- Debt / equity
- —
- Book value / share
- $-0.10
- Revenue growth (YoY)
- −35.9%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2024- Altman Z″ (distress)
- -1957.13distress
- Accruals / assets
- −4119.1%clean
- Piotroski F-Score
- 2/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 3 severe● 5 warning● 2 good- Negative shareholder equity
- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- High leverage (liabilities > 70% of assets)
- Negative operating cash flow
- Strong return on equity (>15%)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Mar 31, 2026
- NT 10-Qmissed a reporting deadline ↗Nov 14, 2025
- NT 10-Qmissed a reporting deadline ↗Aug 14, 2025
- NT 10-Kmissed a reporting deadline ↗Apr 1, 2025
- NT 10-Qmissed a reporting deadline ↗Aug 15, 2024
- NT 10-Qmissed a reporting deadline ↗May 17, 2024
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 38,420 | 1.0 | +450.1% |
| Apr 30, 2026 | 6,984 | 1.0 | -64.8% |
| Apr 15, 2026 | 19,863 | 1.0 | +3243.9% |
| Mar 31, 2026 | 594 | 1.0 | -99.3% |
| Mar 13, 2026 | 83,451 | 1.0 | +55.3% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Director / officer changeMar 27, 2026
- Director / officer change · Regulation FD disclosureOct 21, 2025
- Director / officer changeSep 30, 2025
- Entered a material agreement · Completed an acquisition or disposition · Unregistered equity sale · Regulation FD disclosureJul 15, 2025
- Entered a material agreement · Director / officer changeJun 30, 2025
- Entered a material agreementJun 10, 2025
- Entered a material agreement · Unregistered equity sale · Director / officer changeJul 5, 2024
- Entered a material agreement · New financial obligation · Unregistered equity saleApr 25, 2024
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.